Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori

International Journal of Antimicrobial Agents

Volumn 23, Issue 6, 2004, Pages 631-633

  Spengler, Gabriella ^a   Molnar, Annamaria ^a   Klausz, Gergely ^a   Mandi, Yvette ^a   Kawase, Masami ^b   Motohashi, Noboru ^c   Molnar, Joseph ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b JOSAI UNIVERSITY   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Clarithromycin resistant; Helicobacter pylori; Motility; Proton pump; Trifluoromethyl ketone

Indexed keywords

1 (2 BENZOXAZOLYL) 3,3,3 TRIFLUORO 2 PROPANONE; CLARITHROMYCIN; KETONE DERIVATIVE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; FLAGELLUM; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BENZOXAZOLES; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FLAGELLA; HELICOBACTER PYLORI; KETONES; MICROBIAL SENSITIVITY TESTS; MOVEMENT; PROPANE; PROTON PUMPS;

EID: 2942577937     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.11.010     Document Type: Article

References (11)

1. Kawase M., Harada H., Saito S., Cui J., Tani S. In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones. Bioorg. Med. Chem. Lett. 9:1999;193-194
2. Gerhard M., Rad R., Prinz C., Naumann M. Pathogenesis of Helicobacter pylori infection. Helicobacter. 7:2002;17-23
3. Seydel A., Tasca E., Berti D., Rappuoli R., Giudice G.D., Montecucco C. Characterization and immunogenicity of the CagF protein of the cag pathogenicity island of Helicobacter pylori. Infect Immun. 70:2002;6568-6570
4. Tsutsui N., Taneike I., Ohara T., et al. A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori. Antimicrob. Agents Chemother. 44:2000;3069-3073
5. Josenhans C., Suerbaum S. The role of motility as a virulence factor in bacteria. Int. J. Med. Microbiol. 291:2002;605-614
6. Alarcon T., Domigo D., Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int. J. Antimicro. Agents. 12:1999;19-26
7. Kawase M., Motohashi N., Sakagami H. Antimicrobial activity of trifluoromethyl ketones and their synergism with promethazine. Int. J. Antimicrob. Agents. 18:2001;161-165
8. Eliopoulos GM, Moellerin RC. Antimicrobial combinations. In: Victor L, editors. Antibiotics in laboratory medicine. 3rd ed. Baltimore, MD, USA; 1991. p. 434-41.
9. Eaton K.A., Morgan D.R., Krakowka S. Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. J. Med. Microbiol. 37:1992;123-127
10. Eaton K.A., Suerbaum S., Josenhans C., Krakowka S. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun. 64:1996;2445-2448
11. Ohara T., Goshi S., Taneike I., Tamura Y., Zhang H.M., Yamamoto T. Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori. Helicobacter. 2:2001;125-129